{"id":30375,"date":"2025-05-23T09:48:53","date_gmt":"2025-05-23T08:48:53","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=30375"},"modified":"2025-05-23T10:15:30","modified_gmt":"2025-05-23T09:15:30","slug":"communique-de-presse-ministere-de-la-sante","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/","title":{"rendered":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action &#8211; Communiqu\u00e9 de presse"},"content":{"rendered":"\n<p class=\"has-small-font-size\">Communiqu\u00e9 de presse du Minist\u00e8re du Travail, de la Sant\u00e9, des Solidarit\u00e9s et des Familles &#8211; Paris, le 20 mai 2025<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>\u00c0 l\u2019occasion de l\u2019Assembl\u00e9e mondiale de la Sant\u00e9 du 19 au 27 mai 2025, et de la Session g\u00e9n\u00e9rale de l\u2019Organisation mondiale de la sant\u00e9 animale du 26 au 30 mai 2025, la France rappelle l\u2019urgence de lutter contre la r\u00e9sistance aux antimicrobiens (AMR), l\u2019une des dix menaces les plus graves pour la sant\u00e9 mondiale <a href=\"#_ftn1\" id=\"_ftnref1\"><strong>[1]<\/strong><\/a>, et annonce une s\u00e9rie de priorit\u00e9s pour les deux prochaines ann\u00e9es.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Porter la voix de la France \u00e0 l\u2019\u00e9chelle mondiale<\/strong><\/h2>\n\n\n\n<p>Ces derni\u00e8res ann\u00e9es, la France a renforc\u00e9 son implication \u00e0 l\u2019international en mati\u00e8re de lutte contre l\u2018AMR, \u00e0 travers la mise en \u0153uvre de l\u2019approche \u00ab\u00a0Une seule sant\u00e9\u00a0\u00bb, l\u2019une des priorit\u00e9s fix\u00e9es par la <strong>Strat\u00e9gie fran\u00e7aise en sant\u00e9 mondiale<\/strong> (2023-2027). Elle pilote ainsi, via l\u2019Inserm, <strong>l\u2019action conjointe europ\u00e9enne <\/strong>d\u00e9di\u00e9e \u00e0 la lutte contre la r\u00e9sistance aux antimicrobiens et les infections associ\u00e9es aux soins (EU-JAMRAI 2). Dans les prochaines ann\u00e9es, la France poursuivra cette dynamique et renforcera son engagement \u00e0 l\u2019international en s\u2019investissant pleinement au sein de futures \u00e9ch\u00e9ances sur la th\u00e9matique.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Des priorit\u00e9s concr\u00e8tes d\u2019ici 2027<\/strong><\/h2>\n\n\n\n<p>Pour mettre en \u0153uvre ces priorit\u00e9s, le Gouvernement lance de nouvelles actions articul\u00e9es autour de la mise en \u0153uvre de l\u2019approche \u00ab Une seule sant\u00e9 \u00bb, qui reconna\u00eet les liens entre sant\u00e9 humaine, sant\u00e9 animale et \u00e9cosyst\u00e8mes :<\/p>\n\n\n\n<ul>\n<li><strong>Renforcer la recherche<\/strong> : le <strong>programme prioritaire de recherche pilot\u00e9 par l\u2019Inserm<\/strong>, lanc\u00e9 en 2021, est prolong\u00e9 jusqu\u2019en 2026. Un <strong>appel \u00e0 projets compl\u00e9mentaire<\/strong> sera publi\u00e9 d\u00e8s 2025 pour explorer les champs insuffisamment \u00e9tudi\u00e9s ;<\/li>\n\n\n\n<li><strong>Mieux surveiller pour mieux agir<\/strong> : un <strong>groupe de travail conjoint Anses\/Sant\u00e9 publique France<\/strong> sera lanc\u00e9 \u00e0 la rentr\u00e9e 2025, pour d\u00e9velopper la surveillance int\u00e9gr\u00e9e, afin de mieux analyser les r\u00e9sistances et ainsi ajuster les politiques. De plus, une strat\u00e9gie ambitieuse d\u2019analyse de donn\u00e9es pourrait s\u2019appuyer sur le <strong>Health Data Hub<\/strong> et le <strong>Green Data for Health,<\/strong> pour am\u00e9liorer la pr\u00e9diction et l\u2019action publique\u00a0;<\/li>\n\n\n\n<li><strong>Pr\u00e9server les traitements existants <\/strong>: un travail conjoint en sant\u00e9 humaine et animale sera men\u00e9 en vue de proposer diverses mesures permettant de maintenir un <strong>arsenal th\u00e9rapeutique diversifi\u00e9<\/strong> indispensable pour garantir l\u2019efficacit\u00e9 des antimicrobiens\u00a0;<\/li>\n\n\n\n<li><strong>Sensibiliser largement<\/strong> : la <strong>Conf\u00e9rence nationale de sant\u00e9<\/strong> sera mobilis\u00e9e pour identifier les leviers les plus efficaces de communication et de pr\u00e9vention.<\/li>\n\n\n\n<li><strong>Former pour pr\u00e9venir<\/strong> : en septembre 2025<strong> \u00e0 Toulouse<\/strong>, une <strong>nouvelle \u00e9cole universitaire de recherche <\/strong>dispensera une formation sur l\u2019antibior\u00e9sistance selon l\u2019approche \u00ab Une seule sant\u00e9 \u00bb.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Une strat\u00e9gie sur 10 ans pour structurer l\u2019action<\/strong><\/h2>\n\n\n\n<p>Toutes ces mesures sont issues de la <strong>feuille de route interminist\u00e9rielle 2024-2034<\/strong>, adopt\u00e9e en septembre 2024. Elle repose sur cinq axes structurants :<\/p>\n\n\n\n<ol>\n<li>Mobilisation de tous les acteurs<\/li>\n\n\n\n<li>Renforcement de la recherche<\/li>\n\n\n\n<li>Optimisation de la surveillance<\/li>\n\n\n\n<li>Pr\u00e9servation de l\u2019arsenal th\u00e9rapeutique<\/li>\n\n\n\n<li>Rayonnement international de la France.<\/li>\n<\/ol>\n\n\n\n<p>Sa mise en \u0153uvre est pilot\u00e9e par le <strong>Secr\u00e9tariat g\u00e9n\u00e9ral des affaires europ\u00e9ennes (SGAE)<\/strong>, <strong>sept minist\u00e8res<\/strong> (\u00c9ducation nationale, Sant\u00e9, \u00c9conomie, Europe et Affaires \u00e9trang\u00e8res, \u00c9cologie, Agriculture, Enseignement sup\u00e9rieur et Recherche), ainsi que <strong>six agences ou op\u00e9rateurs<\/strong> :<\/p>\n\n\n\n<ul>\n<li>Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)\u00a0;<\/li>\n\n\n\n<li>Agence nationale de s\u00e9curit\u00e9 sanitaire de l\u2019alimentation, de l\u2019environnement et du travail (Anses)\u00a0;<\/li>\n\n\n\n<li>Caisse nationale de l&#8217;Assurance maladie (Cnam)\u00a0;<\/li>\n\n\n\n<li>Haute Autorit\u00e9 de sant\u00e9 (HAS)\u00a0;<\/li>\n\n\n\n<li>Institut national de la sant\u00e9 et de la recherche m\u00e9dicale (Inserm)\u00a0;<\/li>\n\n\n\n<li>Sant\u00e9 publique France (SpF).<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>R\u00e9sistance aux antimicrobiens<\/strong><strong>&nbsp;<\/strong><strong>: l\u2019urgence d\u2019agir.<\/strong><strong><\/strong><\/td><\/tr><tr><td><em>La r\u00e9sistance aux antimicrobiens (ou AMR pour antimicrobial resistance) survient lorsque certains micro-organismes (bact\u00e9ries, virus, champignons et parasites) \u00e9voluent au cours du temps et ne r\u00e9agissent plus aux m\u00e9dicaments, qui perdent en efficacit\u00e9. Cette\u00a0r\u00e9sistance\u00a0rend plus complexe le traitement des infections et augmente le risque de propagation, de formes graves des maladies et de d\u00e9c\u00e8s. Face \u00e0 l\u2019\u00e9mergence de nouvelles maladies et \u00e0 la multiplication des r\u00e9sistances, il est urgent de pr\u00e9server l\u2019arsenal th\u00e9rapeutique existant.<\/em><br>Des chiffres <a href=\"#_ftn1\" id=\"_ftnref1\">[2]<\/a><sup> <\/sup>qui interpellent\u00a0: <br>&#8211; <strong>France<\/strong> : <strong>104 000 cas<\/strong> <strong>d\u2019infections \u00e0 bact\u00e9ries r\u00e9sistantes<\/strong> chaque ann\u00e9e, avec pr\u00e8s de <strong>4\u00a0500 d\u00e9c\u00e8s<\/strong> li\u00e9s \u00e0 des bact\u00e9ries multi-r\u00e9sistantes<br>&#8211; <strong>Europe<\/strong> : plus de <strong>865 000 cas d\u2019infections \u00e0 bact\u00e9ries r\u00e9sistantes<\/strong> par an, avec plus de <strong>38\u00a0000 d\u00e9c\u00e8s<\/strong> li\u00e9s \u00e0 la r\u00e9sistance aux antimicrobiens.<br>&#8211; <strong>Monde<\/strong> : <strong>39 millions de d\u00e9c\u00e8s cumul\u00e9s<\/strong> li\u00e9s \u00e0 la r\u00e9sistance aux antimicrobiens pourraient survenir d\u2019ici 2050.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"#_ftnref1\" id=\"_ftn1\">[1]<\/a> Source OMS&nbsp;: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/antimicrobial-resistance#:~:text=L&#8217;OMS%20a%20d%C3%A9clar%C3%A9%20que,de%20pathog%C3%A8nes%20r%C3%A9sistants%20aux%20m%C3%A9dicaments.<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"#_ftnref1\" id=\"_ftn1\">[2]<\/a> Sur les donn\u00e9es FR\u00a0: <a href=\"https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Annex_2_burden_estimates_country_sheets.pdf\">Revised estimates of burden of disease for antimicrobial resistance<\/a> <\/p>\n\n\n\n<p class=\"has-small-font-size\">Sur les donn\u00e9es EU\u00a0: <a href=\"https:\/\/www.ecdc.europa.eu\/en\/publications-data\/health-burden-infections-antibiotic-resistant-bacteria-2016-2020\">Assessing the health burden of infections with antibiotic-resistant bacteria in the EU\/EEA, 2016-2020<\/a><\/p>\n\n\n\n<p class=\"has-small-font-size\">Sur les donn\u00e9es monde&nbsp;: <a href=\"https:\/\/www.ecdc.europa.eu\/en\/publications-data\/health-burden-infections-antibiotic-resistant-bacteria-2016-2020\">Assessing the health burden of infections with antibiotic-resistant bacteria in the EU\/EEA, 2016-2020<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"has-small-font-size\">Contacts presse<\/p>\n\n\n\n<ul>\n<li class=\"has-small-font-size\">Direction g\u00e9n\u00e9rale de la sant\u00e9<br>presse-dgs@sante.gouv.fr \/ 01 87 05 92 12<\/li>\n\n\n\n<li class=\"has-small-font-size\">Minist\u00e8re de l\u2019Agriculture et de la Souverainet\u00e9 alimentaire<br>ministere.presse@agriculture.gouv.fr \/ 01 49 55 60 11<\/li>\n\n\n\n<li class=\"has-small-font-size\">Minist\u00e8re de la Transition \u00e9cologique, de la Biodiversit\u00e9, de la For\u00eat, de la Mer et de la P\u00eache<br>presse@ecologie.gouv.fr<\/li>\n\n\n\n<li class=\"has-small-font-size\">Minist\u00e8re de l\u2019Europe et des Affaires \u00e9trang\u00e8res<br>presse.dcp@diplomatie.gouv.fr<br>T\u00e9l : +33 (0) 1 43 17 52 01<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-19e386a6-052d-4bee-ae50-f7ddbe69b3b5\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/05\/COMMUNIQUE-DE-PRESSE-AMR-OH-2025-1.docx\">COMMUNIQUE-DE-PRESSE-AMR-OH-2025-1<\/a><a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/05\/COMMUNIQUE-DE-PRESSE-AMR-OH-2025-1.docx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-19e386a6-052d-4bee-ae50-f7ddbe69b3b5\">T\u00e9l\u00e9charger<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Communiqu\u00e9 de presse du Minist\u00e8re du Travail, de la Sant\u00e9, des Solidarit\u00e9s et des Familles &#8211; Paris, le 20 mai 2025 \u00c0 l\u2019occasion de l\u2019Assembl\u00e9e mondiale de la Sant\u00e9 du 19 au 27 mai 2025, et de la Session g\u00e9n\u00e9rale de l\u2019Organisation mondiale de la sant\u00e9 animale du 26 au 30 mai 2025, la France [&hellip;]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[6697,6607,6733,6698,6685],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-23T08:48:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-23T09:15:30+00:00\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action &#8211; Communiqu\u00e9 de presse\",\"datePublished\":\"2025-05-23T08:48:53+00:00\",\"dateModified\":\"2025-05-23T09:15:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\"},\"wordCount\":962,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antibiotic Resistance\",\"Antimicrobial Resistance\",\"communiqu\u00e9 de presse\"],\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\",\"name\":\"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"datePublished\":\"2025-05-23T08:48:53+00:00\",\"dateModified\":\"2025-05-23T09:15:30+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action \u2013 Communiqu\u00e9 de presse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-05-23T08:48:53+00:00","article_modified_time":"2025-05-23T09:15:30+00:00","author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Kevin Gr\u00e9goire","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action &#8211; Communiqu\u00e9 de presse","datePublished":"2025-05-23T08:48:53+00:00","dateModified":"2025-05-23T09:15:30+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/"},"wordCount":962,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"keywords":["AMR","Antibior\u00e9sistance","Antibiotic Resistance","Antimicrobial Resistance","communiqu\u00e9 de presse"],"articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/","name":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action - Communiqu\u00e9 de presse - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"datePublished":"2025-05-23T08:48:53+00:00","dateModified":"2025-05-23T09:15:30+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/communique-de-presse-ministere-de-la-sante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"R\u00e9sistance aux antimicrobiens : la France renforce son engagement international et se donne des priorit\u00e9s d\u2019action \u2013 Communiqu\u00e9 de presse"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-03 13:10:44","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30375"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=30375"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30375\/revisions"}],"predecessor-version":[{"id":30383,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30375\/revisions\/30383"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=30375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=30375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=30375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}